[OS3-7B-5] Daratumumab treatment for relapsed/refractory multiple myeloma
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.
Oral Session
Sun. Oct 13, 2019 10:10 AM - 11:10 AM No.7 (Tokyo International Forum, 5F Hall D5)
Chair: Hirohiko Shibayama (Department of Hematology and Oncology, Osaka University Graduate School of Medicine)
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.